Some animal studies have shown that transplanted MSCs can migrate to injured sites of the brain, differentiate into neuron-like cells expressing microtubule association protein-2 (MAP2) and glial fibrillary acidic protein (GFAP), and improve neurological function after stroke and spinal cord injury [21, 22]. This evidence concerns the gene MAP2 and Stroke.